Post-Test A Focus on Functional Recovery in MDD: Patient-Centered Strategies to Address Residual Symptoms and Treatment-Emergent Adverse Emergent Adverse Effects Post-Test Which of the following residual symptoms has the most impact on time to remission and recovery? Anhedonia Cognitive symptoms Emotional blunting Fatigue Which of the following statements regarding residual symptoms associated with MDD in the context of antidepressant treatment is TRUE? Cognitive dysfunction is one of the most commonly reported residual symptoms among patients who achieve symptomatic remission Partial remission significantly decreases the likelihood of relapse and/or treatment discontinuation Residual symptoms of MDD are clearly distinguishable from adverse effects of antidepressants Trials designed to show the efficacy of antidepressant strategies commonly focus on patients with partially remitted MDD Real-world data from the RELIEVE study showed improvements in functioning, depression symptom severity, and cognitive function scores for which of the following antidepressants? Duloxetine Levomilnacipran Vilazodone Vortioxetine Please rate your confidence in implementing appropriate antidepressant switching strategies for patients with MDD to mitigate residual symptoms and/or TEAEs. Very confident Confident Somewhat confident Not very confident Not at all confident Previous
